Back to search

Peptide record

TPDB92411

R-DIM-P-LF11-322 Antibacterial Anticancer Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92411
R-DIM-P-LF11-322
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 19-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
PFWRIRIRRPRRIRIRWFP-NH2
Physicochemical Analysis
C127H201N45O20
ANDCEQGHLKMSTYV
R
2678.28
13.25
8
0
8
+8
0.63
-1.000
82.11
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
11000
410.71
0
Residue Composition
number
0
A
8
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
4
I
0
L
0
K
0
M
2
F
3
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 8 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 4 L: 0 K: 0 M: 0 F: 2 P: 3 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
19
C127H201N45O20
2678.28
13.25
+8
0.63
-1.000
Amidation
L
Linear
Free
Host Defence Peptide Anticancer
Synthetic
Evidence Records 7 records
Evidence 1 Activity

Activity

LC50
LC50 = 9.5 ± 0.3 µM
Anticancer
9.5

Target

Skin Cancer
A-375
Skin

Assay & Model

PI uptake assay
8-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015
EP_2943215_B1

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

LC50
LC50 = 5.9 ± 0.3 µM
Anticancer
5.9

Target

Skin Cancer
SBcl2
Skin

Assay & Model

PI uptake assay
8-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015
EP_2943215_B1
Evidence 3 Activity

Activity

LC50
LC50 = 23.3 ± 1.7 µM
Anticancer
23.3

Target

Skin Cancer
A-375
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015
EP_2943215_B1
Evidence 4 Activity

Activity

LC50
LC50 = 10.4 ± 0.7 µM
Anticancer
10.4

Target

Skin Cancer
SBcl2
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015
EP_2943215_B1
Evidence 5 Activity

Activity

LC50
LC50 = 4.2 ± 0.2 µM
Anticancer
4.2

Target

Skin Cancer
A-375
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
EP_2943215_B1
Evidence 6 Activity

Activity

LC50
LC50 = 2.5 ± 0.1 µM
Anticancer
2.5

Target

Skin Cancer
SBcl2
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
EP_2943215_B1
Evidence 7 Activity

Activity

LC50
LC50 = 4.7 ± 0.2 µM
Anticancer
4.7

Target

Skin Cancer
WM164
Skin

Assay & Model

MTS assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2020
EP_2943215_B1